NANOVIRICIDES, INC. (NNVC) › Cash & EquivalentsNANOVIRICIDES, INC. (NNVC) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2005: $02009: $1.69M2010: $7.68M2011: $9.22M2012: $14.27M2013: $13.92M2014: $36.70M2015: $31.47M2016: $24.16M2017: $15.10M2018: $7.08M2019: $2.56M2020: $13.71M2021: $20.52M2022: $14.07M2023: $8.15M2024: $4.80M2025: $1.56M$1.56M2005Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$1.56M-67.5%2024$4.80M-41.1%2023$8.15M-42.1%2022$14.07M-31.4%2021$20.52M+49.7%2020$13.71M+436.5%2019$2.56M-63.9%2018$7.08M-53.1%2017$15.10M-37.5%2016$24.16M-23.2%2015$31.47M-14.2%2014$36.70M+163.6%2013$13.92M-2.5%2012$14.27M+54.8%2011$9.22M+20.1%2010$7.68M+354.4%2009$1.69M—2005$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share